Is artelo Biosciences (Artl) a buy or sell?
According to the issued ratings of 3 analysts in the last year, the consensus rating for Artelo Biosciences stock is Buy based on the current 3 buy ratings for ARTL. The average twelve-month price target for Artelo Biosciences is $4.67 with a high price target of $7.00 and a low price target of $3.00.
Where can I buy Artl shares?
Shares of ARTL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
How do I contact Artl Biosciences?
Artelo Biosciences' mailing address is 888 Prospect Street Suite 210, La Jolla CA, 92037. The company can be reached via phone at (858) 925-7049 or via email at [email protected]. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks.
Is Artl stock a good buy?
Artelo Biosciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
Will Artl go up?
Artelo Biosciences Inc (NASDAQ:ARTL) The 2 analysts offering 12-month price forecasts for Artelo Biosciences Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +1,175.51% increase from the last price of 0.31.
Should I invest in Artelo Biosciences?
Is Artelo Biosciences Stock a good buy in 2022, according to Wall Street analysts? The consensus among 1 Wall Street analyst covering (NASDAQ: ARTL) stock is to Buy ARTL stock.
Is ARTL stock a buy right now?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Artelo Biosciences in the last year. There are currently 3 buy ratings for...
Will Artelo Biosciences' stock price go up in 2022?
3 equities research analysts have issued 1 year price objectives for Artelo Biosciences' stock. Their forecasts range from $3.00 to $7.00. On avera...
How has Artelo Biosciences' stock price performed in 2022?
Artelo Biosciences' stock was trading at $0.5190 at the beginning of the year. Since then, ARTL stock has decreased by 26.8% and is now trading at...
Are investors shorting Artelo Biosciences?
Artelo Biosciences saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 553,600 shares, a de...
When is Artelo Biosciences' next earnings date?
Artelo Biosciences is scheduled to release its next quarterly earnings announcement on Monday, July 11th 2022. View our earnings forecast for Arte...
How were Artelo Biosciences' earnings last quarter?
Artelo Biosciences, Inc. (NASDAQ:ARTL) issued its quarterly earnings data on Wednesday, January, 12th. The company reported ($0.08) EPS for the qua...
Who are Artelo Biosciences' key executives?
Artelo Biosciences' management team includes the following people: Mr. Gregory D. Gorgas M.B.A. , Pres, CEO, CFO, Treasurer, Sec. & Director (Ag...
Who are some of Artelo Biosciences' key competitors?
Some companies that are related to Artelo Biosciences include Akari Therapeutics (AKTX) , Orgenesis (ORGS) , eFFECTOR Therapeutics (EFTR) , PLx...
What other stocks do shareholders of Artelo Biosciences own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Artelo Biosciences investors own include NVIDIA (NVDA) ,...
When will Artelo Biosciences release its earnings?
What is the P/E ratio of Artelo Biosciences?
Artelo Biosciences is scheduled to release its next quarterly earnings announcement on Wednesday, November 3rd 2021. View our earnings forecast for Artelo Biosciences.
Where is Artelo Biosciences located?
The P/E ratio of Artelo Biosciences is -1.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Is Artelo Biosciences a buy?
The company was founded by James Manley on May 2, 2011 and is headquartered in Solana Beach, CA.
Does Artelo pay dividends?
Artelo Biosciences has received a consensus rating of Buy . The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
Artelo Biosciences Reports First Quarter Fiscal Year 2022 Financial Results and Provides Business Update
Artelo Biosciences does not currently pay a dividend.
Artelo Anticipates Accelerated Clinical Development for ART27.13 Following Its Classification Change in the United Kingdom
Complete Enrollment of Phase 1 CAReS Trial Anticipated by End of First Quarter of Calendar Year 2022 $26.4 Million in Cash and Marketable Securities as of November 30, 2021 SOLANA BEACH, Calif., Jan. 12, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc.
Artelo Biosciences Leadership to Participate on Endocannabinoid Panel at the H.C. Wainwright BioConnect 2022 Virtual Conference
SOLANA BEACH, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc.
Component Grades
Artelo CEO also providing corporate outlook for 2022 at the H.C. Wainwright ConferenceSOLANA BEACH, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc.
The Trend in the Analyst Price Target
We have 9 different ratings for every stock to help you appreciate its future potential. You can unlock it all now.
ARTL Broker Recommendations Summary
Over the past 12 months, ARTL's average price target has gone up $1.67.
What is the price target for Artl 2021?
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Is Artelo Biosciences oversold?
On Nov 01, 2021 "HC Wainwright" gave "" rating for ARTL. The price target was changed from $0.72 to 3.2% .
Is Bollinger Band stock high risk?
Artelo Biosciences, Inc. is oversold on RSI14 (10). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.
Is Artelo Biosciences, Inc. stock A Buy?
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.12 between high and low, or 18.10%. For the last week, the stock has had a daily average volatility of 9.83% .
ARTL earnings per share forecast
holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
ARTL revenue forecast
What is ARTL 's earnings per share in the next 3 years based on estimates from 2 analyst s?
